Unraveling the intricacies of receptor activated cell signaling and transcriptional cascades enhance opportunities to develop new therapeutic targets for endocrine and metabolic diseases.
Firestone
Gary L
GL
D015195:Drug Design; D004700:Endocrine System Diseases / Q000188:drug therapy*; D006801:Humans; D008659:Metabolic Diseases / Q000188:drug therapy*; D058990:Molecular Targeted Therapy / Q000009:adverse effects; D015398:Signal Transduction; D015533:Transcriptional Activation / Q000187:drug effects